Terms: = Pancreatic cancer AND NONO, Q15233, 4841, ENSG00000147140, NRB54, P54NRB, NMT55, P54
42 results:
1. VHL suppresses autophagy and tumor growth through PHD1-dependent Beclin1 hydroxylation.
Wang Z; Yan M; Ye L; Zhou Q; Duan Y; Jiang H; Wang L; Ouyang Y; Zhang H; Shen Y; Ji G; Chen X; Tian Q; Xiao L; Wu Q; Meng Y; Liu G; Ma L; Lei B; Lu Z; Xu D
EMBO J; 2024 Mar; 43(6):931-955. PubMed ID: 38360997
[TBL] [Abstract] [Full Text] [Related]
2. Causal relationships between risk of venous thromboembolism and 18 cancers: a bidirectional Mendelian randomization analysis.
Cornish N; Haycock P; Brenner H; Figueiredo JC; Galesloot TE; Grant RC; Johansson M; Mariosa D; McKay J; Pai R; Pellatt AJ; Samadder NJ; Shi J; Thibord F; Trégouët DA; Voegele C; Thirlwell C; Mumford A; Langdon R;
Int J Epidemiol; 2024 Feb; 53(1):. PubMed ID: 38124529
[TBL] [Abstract] [Full Text] [Related]
3. Relationship between ABO Blood Group Alleles and pancreatic cancer Is Modulated by Secretor (FUT2) Genotype, but Not Lewis Antigen (FUT3) Genotype.
Kim J; Yuan C; Amundadottir LT; Wolpin BM; ; Klein AP; ; Risch HA; Kraft P
Cancer Epidemiol Biomarkers Prev; 2023 Sep; 32(9):1242-1248. PubMed ID: 37342060
[TBL] [Abstract] [Full Text] [Related]
4. Significance of liquid-liquid phase separation (LLPS)-related genes in breast cancer: a multi-omics analysis.
Xie J; Chen L; Wu D; Liu S; Pei S; Tang Q; Wang Y; Ou M; Zhu Z; Ruan S; Wang M; Shi J
Aging (Albany NY); 2023 Jun; 15(12):5592-5610. PubMed ID: 37338518
[TBL] [Abstract] [Full Text] [Related]
5. Epidemiological and genetic evidence for the relationship between ABO blood group and human cancer.
Cui H; Qu Y; Zhang L; Zhang W; Yan P; Yang C; Zhang M; Bai Y; Tang M; Wang Y; Chen L; Xiao C; Zou Y; Liu Y; Zhang L; Yang Y; Yao Y; Li J; Liu Z; Yang C; Jiang X; Zhang B
Int J Cancer; 2023 Jul; 153(2):320-330. PubMed ID: 37074298
[TBL] [Abstract] [Full Text] [Related]
6. Helicobacter pylori Seropositivity, ABO Blood Type, and pancreatic cancer Risk From 5 Prospective Cohorts.
Lee AA; Wang QL; Kim J; Babic A; Zhang X; Perez K; Ng K; Nowak J; Rifai N; Sesso HD; Buring JE; Anderson GL; Wactawski-Wende J; Wallace R; Manson JE; Giovannucci EL; Stampfer MJ; Kraft P; Fuchs CS; Yuan C; Wolpin BM
Clin Transl Gastroenterol; 2023 May; 14(5):e00573. PubMed ID: 36854058
[TBL] [Abstract] [Full Text] [Related]
7. pancreatic cancer among solid organ transplant recipients in the United States.
Tanaka T; Lynch CF; Yu KJ; Morawski BM; Hsieh MC; Alverson G; Austin AA; Zeng Y; Engels EA
J Cancer Res Clin Oncol; 2023 Jul; 149(7):3325-3333. PubMed ID: 35932302
[TBL] [Abstract] [Full Text] [Related]
8. The prognostic impact of ABO blood type in pancreatic cancer: Relevance to adjuvant chemotherapy.
Tezuka K; Ohgi K; Okamura Y; Sugiura T; Ito T; Yamamoto Y; Ashida R; Otsuka S; Todaka A; Uesaka K
J Hepatobiliary Pancreat Sci; 2022 Aug; 29(8):922-931. PubMed ID: 35435311
[TBL] [Abstract] [Full Text] [Related]
9. ABO blood group type and risk of venous thromboembolism in patients with cancer.
Englisch C; Moik F; Nopp S; Raderer M; Pabinger I; Ay C
Blood Adv; 2022 Dec; 6(24):6274-6281. PubMed ID: 35416922
[TBL] [Abstract] [Full Text] [Related]
10. The age-dependent association of risk factors with pancreatic cancer.
Yuan C; Kim J; Wang QL; Lee AA; Babic A; ; Amundadottir LT; Klein AP; Li D; McCullough ML; Petersen GM; Risch HA; Stolzenberg-Solomon RZ; Perez K; Ng K; Giovannucci EL; Stampfer MJ; Kraft P; Wolpin BM
Ann Oncol; 2022 Jul; 33(7):693-701. PubMed ID: 35398288
[TBL] [Abstract] [Full Text] [Related]
11. ABO blood group distribution and risk of malignancy in patients undergoing resection for intraductal papillary mucinous neoplasm (IPMN).
Zelga P; Hernández-Barco YG; Qadan M; Ferrone CR; Baba T; Bolm L; Jah A; Warshaw AL; Lillemoe KD; Balakrishnan A; Fernández-Del Castillo C
Pancreatology; 2022 Mar; 22(2):264-269. PubMed ID: 35000863
[TBL] [Abstract] [Full Text] [Related]
12. Influence of cancer Susceptibility Gene Mutations and ABO Blood Group of pancreatic cancer Probands on Concomitant Risk to First-Degree Relatives.
Antwi SO; Rabe KG; Bamlet WR; Meyer M; Chandra S; Fagan SE; Hu C; Couch FJ; McWilliams RR; Oberg AL; Petersen GM
Cancer Epidemiol Biomarkers Prev; 2022 Feb; 31(2):372-381. PubMed ID: 34782396
[TBL] [Abstract] [Full Text] [Related]
13. O-positive blood type is associated with prolonged recurrence-free survival following curative resection of pancreatic neuroendocrine tumors.
De Rycke O; Védie AL; Guarneri G; Nin F; De Flori C; Hentic O; Idri S; Sauvanet A; Rebours V; Cros J; Couvelard A; Ruszniewski P; de Mestier L
Pancreatology; 2020 Dec; 20(8):1718-1722. PubMed ID: 33032924
[TBL] [Abstract] [Full Text] [Related]
14. The ABO Blood Group Impacts the Survival of Patients Undergoing Pancreatoduodenectomy for Biliary Tract cancer.
Mori S; Aoki T; Tago K; Shimizu T; Harada N; Park KH; Sakuraoka Y; Shiraki T; Iso Y; Kubota K
In Vivo; 2020; 34(4):1893-1900. PubMed ID: 32606160
[TBL] [Abstract] [Full Text] [Related]
15. ABO blood type, smoking status, other risk factors and prognosis of pancreatic ductal adenocarcinoma.
Li SS; Zhou CY; Liao R; Xiong L; Weng NN; Zhao YQ; Mason C; Gou HF; Yi C; Zhu Q
Medicine (Baltimore); 2020 Apr; 99(14):e19413. PubMed ID: 32243360
[TBL] [Abstract] [Full Text] [Related]
16. Association of ABO blood group with survival following pancreatoduodenectomy for pancreatic ductal adenocarcinoma.
Williams H; Jajja MR; Hashmi SS; Maxwell D; Cardona K; Maithel SK; Russell MC; Sarmiento JM; Winer JH; Kooby DA
HPB (Oxford); 2020 Nov; 22(11):1557-1562. PubMed ID: 32146119
[TBL] [Abstract] [Full Text] [Related]
17. Blood Type as a Predictor of High-Grade Dysplasia and Associated Malignancy in Patients with Intraductal Papillary Mucinous Neoplasms.
Poruk KE; Griffin J; Makary MA; He J; Cameron JL; Weiss MJ; Wood LD; Goggins M; Wolfgang CL
J Gastrointest Surg; 2019 Mar; 23(3):477-483. PubMed ID: 30187322
[TBL] [Abstract] [Full Text] [Related]
18. pancreatic cancer risk is modulated by inflammatory potential of diet and ABO genotype: a consortia-based evaluation and replication study.
Antwi SO; Bamlet WR; Pedersen KS; Chaffee KG; Risch HA; Shivappa N; Steck SE; Anderson KE; Bracci PM; Polesel J; Serraino D; La Vecchia C; Bosetti C; Li D; Oberg AL; Arslan AA; Albanes D; Duell EJ; Huybrechts I; Amundadottir LT; Hoover R; Mannisto S; Chanock SJ; Zheng W; Shu XO; Stepien M; Canzian F; Bueno-de-Mesquita B; Quirós JR; Zeleniuch-Jacquotte A; Bruinsma F; Milne RL; Giles GG; Hébert JR; Stolzenberg-Solomon RZ; Petersen GM
Carcinogenesis; 2018 Jul; 39(8):1056-1067. PubMed ID: 29800239
[TBL] [Abstract] [Full Text] [Related]
19. Associations between ABO blood groups and pancreatic ductal adenocarcinoma: influence on resection status and survival.
El Jellas K; Hoem D; Hagen KG; Kalvenes MB; Aziz S; Steine SJ; Immervoll H; Johansson S; Molven A
Cancer Med; 2017 Jul; 6(7):1531-1540. PubMed ID: 28556564
[TBL] [Abstract] [Full Text] [Related]
20. Modifiable and non-modifiable risk factors for pancreatic cancer: A review.
Midha S; Chawla S; Garg PK
Cancer Lett; 2016 Oct; 381(1):269-77. PubMed ID: 27461582
[TBL] [Abstract] [Full Text] [Related]
[Next]
